New hope for shortness of breath after lung clot surgery?
NCT ID NCT03409588
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called riociguat in 10 adults who still had trouble exercising at least 6 months after surgery for chronic blood clots in the lungs. The goal was to see if the drug could improve blood pressure in the lungs and make exercise easier. Participants took the drug for 3 months and had heart tests and walking tests to measure changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC THROMBOEMBOLIC DISEASE (CTED) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado, Anschutz Medical Campus
Aurora, Colorado, 80045, United States